机译:纯化的Vero细胞培养的狂犬病患者(Speya)在暴露后受试者中施用的纯化的Vero细胞培养的狂犬病疫苗(Speya)的免疫原性,安全性和抗体持续性
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Liaoning Chengda Biol Ltd Share Ltd Shenyang Peoples R China;
Guangdong Prov Ctr Dis Control &
Prevent Guangzhou Guangdong Peoples R China;
Wuhan City Ctr Dis Control &
Prevent Wuhan Peoples R China;
Guizhou Prov Ctr Dis Control &
Prevent Guiyang Peoples R China;
Hunan Prov Ctr Dis Control &
Prevent Changsha Hunan Peoples R China;
Natl Inst Food &
Drug Control Beijing Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Guizhou Prov Ctr Dis Control &
Prevent Guiyang Peoples R China;
Chaoyang Dist Ctr Dis Control &
Prevent 25 Huaweili Beijing 100021 Peoples R China;
Post-exposure; Protective effect; Rabies vaccine; Safety; Immunogenicity;
机译:纯化的Vero细胞培养的狂犬病患者(Speya)在暴露后受试者中施用的纯化的Vero细胞培养的狂犬病疫苗(Speya)的免疫原性,安全性和抗体持续性
机译:按照接触后方案在中国健康儿童和成人中给药时,下一代无血清,高度纯化的Vero细胞狂犬病疫苗是安全的,并且具有与参考疫苗Verorab(R)一样的免疫原性。
机译:狂犬病暴发后预防性接种疫苗的四点皮内时间表(4-0-2-0-1-1):采用纯化的鸡胚细胞疫苗(PCECV)和纯化的Vero细胞狂犬病疫苗(PVRV):有效和实用的方案
机译:Zagreb方案或Essen方案对暴露后受试者施用纯化的Vero细胞培养的狂犬病疫苗(Speeda)的免疫原性安全性和抗体持久性
机译:按照接触后方案在中国健康儿童和成人中给药时,下一代无血清,高度纯化的Vero细胞狂犬病疫苗是安全的,并且具有与参考疫苗Verorab®一样的免疫原性。